Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Diel

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Seminars in Oncology|September 7, 2001
Bisphosphonates in the prevention of bone metastases: current evidenceI J Diel
Future Oncology (London, England)|March 25, 2006
Ibandronate: efficacy in the treatment of metastatic bone diseaseIngo J Diel
Seminars in Oncology|June 13, 2001
Bone marrow staging for breast cancer: is it better than axillary node dissection?I J Diel
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2007
Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a reviewIngo J Diel
Cancer Treatment Reviews|June 22, 2001
Prognostic factors for skeletal relapse in breast cancerI J Diel
Gynakologisch-Geburtshilfliche Rundschau|November 17, 1998
[Bisphosphonates in the adjuvant therapy of breast cancer-- pathophysiology, animal models, and clinical experiences]I J Diel
Breast Care (Basel, Switzerland)|July 23, 2011
Bisphosphonates in Breast Cancer Patients with Bone MetastasesIngo J Diel
Drugs|April 25, 2000
Antitumour effects of bisphosphonates: first evidence and possible mechanismsI J Diel
Medizinische Klinik (Munich, Germany : 1983)|November 23, 2000
[Therapeutic value of aredia in treatment of breast carcinoma]I J Diel
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2004
Rapid administration of ibandronate does not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancyM Pecherstorfer, I J Diel
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|September 7, 2001
Bisphosphonates in the prevention of bone metastases: current evidenceI J Diel
Future Oncology (London, England)|March 25, 2006
Ibandronate: efficacy in the treatment of metastatic bone diseaseIngo J Diel
Seminars in Oncology|June 13, 2001
Bone marrow staging for breast cancer: is it better than axillary node dissection?I J Diel
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2007
Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a reviewIngo J Diel
Cancer Treatment Reviews|June 22, 2001
Prognostic factors for skeletal relapse in breast cancerI J Diel
Gynakologisch-Geburtshilfliche Rundschau|November 17, 1998
[Bisphosphonates in the adjuvant therapy of breast cancer-- pathophysiology, animal models, and clinical experiences]I J Diel
Breast Care (Basel, Switzerland)|July 23, 2011
Bisphosphonates in Breast Cancer Patients with Bone MetastasesIngo J Diel
Drugs|April 25, 2000
Antitumour effects of bisphosphonates: first evidence and possible mechanismsI J Diel
Medizinische Klinik (Munich, Germany : 1983)|November 23, 2000
[Therapeutic value of aredia in treatment of breast carcinoma]I J Diel
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2004
Rapid administration of ibandronate does not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancyM Pecherstorfer, I J Diel
Pageof 9